Evidence map›Paper›PMID 42248859›Full record

ArticleCell death discovery2026

An electrophysiological and proteomics roadmap for human induced glutamatergic neurons: fine-tuning of culture conditions for pathophysiological studies.

Martina Servetti, Giulia Parodi, Martino Caramia, Ennio Nano, Martina Bartolucci, Antonella Marte, Giacomo Mazzoni, Simone Giubbolini, Farah Diab, Andrea Petretto and 7 more

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Martina Servetti *Dipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Giulia Parodi *IRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy.
Martino CaramiaCenter for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genoa, Italy.
Ennio NanoIRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy.
Martina BartolucciCore Facility for Omics Science, IRCCS Istituto Giannina Gaslini, Genoa, Italy.ORCID http://orcid.org/0000-0001-5289-4219
Antonella MarteDipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Giacomo MazzoniDipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Simone GiubboliniDipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Farah DiabDipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Andrea PetrettoCore Facility for Omics Science, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Pierluigi ValenteDipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Sergio MartinoiaIRCCS Azienda Ospedaliera Metropolitana, Genoa, Italy.
Simona BaldassariUnit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.ORCID http://orcid.org/0000-0002-5304-3608
Anna FassioDipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Fabio BenfenatiCenter for Synaptic Neuroscience and Technology, Istituto Italiano di Tecnologia, Genoa, Italy.ORCID http://orcid.org/0000-0002-0653-8368
Anna Corradi *Dipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy.
Bruno Sterlini *Dipartimento di Medicina Sperimentale, Università di Genova, Genoa, Italy. bruno.sterlini@unige.it.ORCID http://orcid.org/0000-0001-8247-4709

Funding

Fondazione Telethon (Telethon Foundation) GJC22066Fondazione Telethon (Telethon Foundation) GMR24T1085Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) #NEXTGENERATIONEUMinistero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) PRIN2022MPCKWW
6 · The paper itself

Abstract

Induced glutamatergic neurons (iGluNeurons) generated by Neurogenin-2 (NGN2) overexpression in human pluripotent stem cells are a powerful model for studying human neuronal maturation and function; however, NGN2-based protocols still lack standardized culture conditions that critically affect neuronal development and function. Three key factors have been identified by previous literature, namely the composition of extracellular matrix coating, the initial plating density, and the choice of culture medium, but the differential effects of their combination have not been thoroughly analyzed. Here, we investigated the combinatorial effects of these three variables, testing eight distinct culture conditions resulting from the combinations of two coatings (poly-L-ornithine and polyethyleneimine), two media (BrainPhys and Neurobasal), and two cell densities (4800 and 1200 cells/mm²). We assessed electrophysiological properties at the single-cell and network levels, characterized morphofunctional and proteomic features across multiple developmental stages. Electrophysiological data indicate that medium composition and plating density, rather than substrate coating, determine neuronal maturation dynamics, with BrainPhys and high density promoting rapid but transient maturation while Neurobasal and low density supporting gradual and sustained network development. Morphofunctional analyzes of synapses and the axon initial segment, together with neuronal maturation markers, support an early BrainPhys-driven acceleration of development that is later exceeded by Neurobasal. To enable accurate proteome profiling of the iGluNeuron system-comprising human neurons and rat astrocytes-we developed a robust taxonomic filtering algorithm that selectively identifies human-specific proteins. This approach confirmed the presence of a conserved core of NGN2-driven differentiation pathways across all settings, in addition to condition-specific signatures. Finally, in the optimal conditions identified through our experimental analyzes, robust spontaneous and evoked synaptic activity was observed. These results provide a framework for optimizing iGluNeuron cultures, balancing rapid maturation and long-term functional stability, and establishing a benchmark for human neuronal models in disease research and drug screening.

Identifiers

PMID42248859
PMCPMC13458295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.